Isuzuma rya Encorafenib Plus Cetuximab na FOLFOX ryihariye mu Bushinwa: Uburyo bwo kuvura kanseri y’inkondo y’umura ya BRAF V600E-Mutant Metastatic

Vuba aha, Ikigo gishinzwe isuzuma ry’imiti (CDE) cy’Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi mu Bushinwa (NMPA) cyatangaje ko Encorafenib yemejwe by’agateganyo kugira ngo isuzumwe mbere y’abandi. Izakoreshwa hamwe na cetuximab hamwe na FOLFOX chemotherapy regimen nk’uburyo bwa mbere bwo kuvura abarwayi bakuru barwaye kanseri y’inkondo y’umura ya BRAF V600E.

Ibi bigaragaza iterambere rikomeye mu buvuzi mpuzamahanga kuri iyi kanseri igoranye kuvura iterwa n’impinduka mu miterere y’uturemangingo.

**Encorafenib ni iki kandi kuki ari ingenzi?**

Encorafenib ni umuti ugabanya cyane imiterere ya ATP, urwanya molekile ntoya za BRAF. Mu magambo make, wibasira neza uturemangingo twa kanseri dutwara BRAF V600E mutation, bikabuza gukura no kwiyongera kwabyo. Ugereranyije n'imiti igabanya imiterere ya BRAF yari yemewe mbere, Encorafenib ifite imikorere miremire mu bijyanye n'imiti, bivuze ko ikomeza kugira akamaro mu mubiri igihe kirekire.

**Amakuru y'ubuvuzi: Ibimenyetso by'uko imikorere yagenze neza**

Ku ya 25 Mutarama 2025, *Nature Medicine* yasohoye inyigo y’icyiciro cya 3 cya Encorafenib + Cetuximab + chemotherapy yo kuvura kanseri y’inkondo y’umura ya BRAF. Inyigo ya BREAKWATER (NCT04607421) yari igamije gusuzuma akamaro ka encorafenib hamwe na cetuximab ifite cyangwa idafite chemotherapy isanzwe ku barwayi ba kanseri y’inkondo y’umura ya BRAF V600E. Abarwayi bose hamwe 236 bashyizwe mu itsinda ry’igerageza na 243 mu itsinda ry’igenzura. Ibisubizo byagaragaje igipimo cy’isuzuma cyemewe cya 60.9% mu itsinda ry’igerageza, aho abarwayi 3 babonye igisubizo cyuzuye (CR), 64 basubije igice (PR), na 31 barwaye indwara idahinduka (SD). Mu itsinda ry’igenzura, cORR yari 40.0%, aho 2 CR, 42 PR, na 34 SD. Igihe cy’isuzuma (DOR) cyari amezi 13.9 n’amezi 11.1, uko bikurikirana. Impuzandengo y'ubuzima rusange ntabwo yagereranywaga mu itsinda ry'igerageza, ugereranyije n'amezi 14.6 mu itsinda ry'igenzura.

**Ku barwayi mpuzamahanga: Ishami Mpuzamahanga ry’Ibitaro bya Oncology bya Beijing mu Karere k’Amajyepfo ritanga uburyo bwo kuvurwa mu buryo bugezweho**

Ubu buryo bwo kuvura bugezweho ubu bwinjiye mu nzira y'ibanze yo gusuzuma mu Bushinwa. Ku barwayi mpuzamahanga—niba wowe cyangwa umwe mu bagize umuryango wawe mushaka uburyo bwiza bwo kuvura—Ishami Mpuzamahanga ry’Ibitaro bya Oncology bya Beijing mu Karere k’Amajyepfo ryiyemeje kuba ikiraro cy’ikoranabuhanga rigezweho ku rwego rw’isi. Dukurikiranira hafi iterambere ry’imiti mpuzamahanga kandi dutanga inama z’umwuga n’ubufasha mu buvuzi ku barwayi babishoboye.

**Twandikire Uyu Munsi Kugirango Utangire Urugendo Rwawe rw'Ibyiringiro**

Ntutegereze. Buri buryo bwo kuvurwa bufite ubushobozi bwo guhindura icyerekezo cy'ubuzima. Itsinda ryacu rishinzwe indimi nyinshi ryiteguye gutanga inama, gahunda yo kubonana n'umuntu, ndetse n'ubuyobozi bw'ubuvuzi.

����Umurongo w'ingenzi: 400-880-3716

����Umuntu wo kuvugana na WeChat ako kanya: ID: 17801183037

����Imeri:

- Primary: `100085_010@163.com`

- Backup: `myimmnet@163.com`

Ushobora kutuvugisha unyuze muri urwo rwego rwose rwavuzwe haruguru. Abahuzabikorwa bacu mpuzamahanga bazahita badufasha mu bijyanye no gutegura inyandiko z'ubuvuzi, gusuzuma uburyo bwo kuvurwa, ndetse no kubaza ibibazo byose bijyanye no gushaka ubuvuzi i Beijing. Ishami Mpuzamahanga ry’Ibitaro bya Oncology bya Beijing mu Karere k’Amajyepfo ryiteguye guhangana nawe n’ibibazo, ribigiranye ubuhanga n’impuhwe.